FLNA
Filana Therapeutics, Inc. NASDAQ Listed Jul 14, 2000$1.22
+0.83%
vs $1.21
Mkt Cap $58.9M
52w Low $1.18
3.1% of range
52w High $2.45
50d MA $1.43
200d MA $1.67
P/E (TTM)
—
EV/EBITDA
—
P/B
0.8x
Debt/Equity
0.0x
ROE
-122.3%
P/FCF
-1.8x
RSI (14)
25.80
ATR (14)
$0.09
Beta
-0.68
50d MA
$1.43
200d MA
$1.67
Avg Volume
374.7K
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
6801 N. Capital of Texas Highway · Austin, TX 78731 · US
Data updated apr 25, 2026 9:21am
· Source: financialmodelingprep.com